Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.

Autor: Musoro J; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Sleurs C; Department of Cognitive Neuropsychology, Tilburg University, Tilburg, The Netherlands.; Department of Paediatric Oncology, KU Leuven, Leuven, Belgium., Rowsell A; 'Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK., Suciu S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Kicinski M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Chantziara S; 'Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK., Coens C; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Pe M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Missotten P; Unité de Psychologie de la Sénescence, Université de Liège, Liège, Belgium., Vandecruys E; Department of Pediatric Hemato-Oncology, Ghent University Hospital, Ghent, Belgium., Uyttebroeck A; Department of Pediatric Hemato-Oncology, University Hospital Leuven, Leuven, Belgium., Dresse MF; Division of Haematology-Oncology, Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium., Pluchart C; Department of Pediatric Haematology and Oncology, CHU Reims, Reims, France., Ferster A; Department of Hemato-Oncology, HUDERF (ULB), Brussels, Belgium., Freycon C; Department of Pediatric Hematology-Oncology, CHU Grenoble, Grenoble, France., Van Der Werff Ten Bosch J; Department of Pediatrics, UZ Brussel, Brussels, Belgium., Rohrlich P; Pediatric Oncology, CHU Nice, Nice, France., Benoit Y; Department of Pediatric Hemato-Oncology, Ghent University Hospital, Ghent, Belgium., Piette C; Division of Haematology-Oncology, Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium., Darlington AS; 'Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov 30, pp. e31446. Date of Electronic Publication: 2024 Nov 30.

Diagnosis of IRAK-4-deficiency by flow cytometric measurement of IκB-α degradation.

Autor: Frans G; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium., Michiels B; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium., Picard C; Necker Medical School, Paris Descartes University, Paris, France.; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.; Imagine Institute, Paris Descartes University Paris, France.; Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, AP-HP Paris, France., Ampofo L; Department of Pharmaceutical and Pharmacological Sciences, Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium., Raes M; Department of Pediatrics, Jessa Hospital, Hasselt, Belgium., Toelen J; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium., Bucciol G; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium., van der Werff Ten Bosch J; Department of Pediatrics, Antwerp Hospital Network, Antwerp, Belgium., Moens L; Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium., Wuyts G; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium., Dillaerts D; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium., Casanova JL; Imagine Institute, Paris Descartes University Paris, France.; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, and Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Howard Hughes Medical Institute, New York, NY, USA., Schrijvers R; Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.; Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium., Meyts I; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium., Bossuyt X; Department of Microbiology, Immunology and Transplantation, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Nov 06; Vol. 62 (4), pp. e102-e105. Date of Electronic Publication: 2023 Nov 06 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.

Autor: van Bladel DAG; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., de Groen RAL; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., de Groot FA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van der Last-Kempkes JLM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Berendsen MR; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Rijntjes J; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Luijks JACW; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Bonzheim I; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., van der Spek E; Department of Hematology, Rijnstate Hospital, Arnhem, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Pruijt JFM; Department of Hematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., de Jonge-Peeters SDPWM; Department of Hematology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands., Lensen C; Department of Hematology, Bernhoven Hospital, Uden, The Netherlands., van Bladel ER; Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands., Federmann B; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.; Department of Translational Immunology, German Cancer Research Center, Medical Hospital Tübingen, Tübingen, Germany., Hoevenaars BM; Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Pastorczak A; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland., van der Werff Ten Bosch J; Department of Pediatric Hematology and Oncology, University Hospital Brussels, Brussels, Belgium.; Department of Pediatrics, Paola Children's Hospital, Antwerp, Belgium., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Nooijen PTGA; Pathology-DNA, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Fend F; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van Krieken JHJM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van den Brand M; Pathology-DNA, Rijnstate Hospital, Arnhem, The Netherlands., Scheijen B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5911-5924.

Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype.

Autor: Cockx M; Department of Microbiology, Immunology and Transplantation, University of Leuven, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, University of Leuven, Leuven, Belgium., Haerynck F; Department of Internal Medicine and Pediatrics, Center for Primary Immunodeficiency, PID research lab, Ghent University, Ghent, Belgium.; Department of Pediatric Pulmonology and Immunology, University Hospital Ghent, Ghent, Belgium., Hoste L; Department of Internal Medicine and Pediatrics, Center for Primary Immunodeficiency, PID research lab, Ghent University, Ghent, Belgium.; Department of Pediatric Pulmonology and Immunology, University Hospital Ghent, Ghent, Belgium., Schrijvers R; Department of Microbiology, Immunology and Transplantation, University of Leuven, Leuven, Belgium.; Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium., Van der Werff Ten Bosch J; Department of Pediatrics, University Hospital Brussels, Brussels, Belgium., Dillaerts D; Department of Microbiology, Immunology and Transplantation, University of Leuven, Leuven, Belgium., Thomas D; PharmAbs, The KU Leuven Antibody Center, University of Leuven, Leuven, Belgium.; Laboratory for Therapeutic and Diagnostic Antibodies, University of Leuven, Leuven, Belgium., Schaballie H; Department of Pediatrics, Division of Primary Immunodeficiencies, University Hospitals Leuven, Leuven, Belgium., Bucciol G; Department of Pediatrics, Division of Primary Immunodeficiencies, University Hospitals Leuven, Leuven, Belgium., Robberechts W; Department of Pediatrics, University Hospital Brussels, Brussels, Belgium., Patel D; UK NEQAS Immunology, Immunochemistry & Allergy, Northern General Hospital, Sheffield, UK., Berbers G; National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands., Desombere I; Department of Infectious Diseases in Humans, Laboratory Immune Response, Sciensano, Brussels, Belgium., Geukens N; PharmAbs, The KU Leuven Antibody Center, University of Leuven, Leuven, Belgium., Meyts I; Department of Pediatrics, Division of Primary Immunodeficiencies, University Hospitals Leuven, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, University of Leuven, Leuven, Belgium., Bossuyt X; Department of Microbiology, Immunology and Transplantation, University of Leuven, Leuven, Belgium.; PharmAbs, The KU Leuven Antibody Center, University of Leuven, Leuven, Belgium.; Laboratory of Clinical and Diagnostic Immunology, Leuven, Belgium.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Sep 21; Vol. 62 (1), pp. 138-149. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2024).